Agilent Technologies Stock News

Healthtech startup Nicoya Lifesciences has raised a healthy $20 million CAD Series A extension to assist in the continuing development and commercialization of its rapid, saliva-based COVID-19 antigen test. Whitecap Venture Partners led the round, which included participation from Agilent Technologies, Export Development Canada, BDC Capital, MaRS IAF, Garage Capital, and others. Their technology is being used every day by scientists who develop life-saving drugs and make key findings about common diseases that affect our lives. The round closed at the end of November. The new financing will go toward new features and functions for Atlas, Nicoyas main The post Nicoyas $20 million Series A extension enables continued development of COVID-19 test first appeared on BetaKit .

The Microinjector Market report is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an elaborate

SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent Technologies Inc. (NYSE: A) today announced the company will deliver presentations at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference and the J.P. Morgan 40th Annual Healthcare Conference. Both conferences will be webcast. Details are included below. Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference Date: Jan. 6, 2022 Time: 11 a.m. ET/8 a.m. PT Presenting for Agilent: Mike McMullen, Agilent chief executive officer B

SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent Technologies Inc. (NYSE: A) today announced the company will deliver presentations at the Goldman Sachs 14th Annual Healthcare CEOs Unscri

CMI Research has released the latest version of its survey report on the Liquid Chromatography Mass Spectrometry (LCMS) Market, which includes 100+ market data tables, a pie chart, graphs and figures scattered over pages. The market is currently expanding its

Key Companies in Next-Generation Sequencing Market are Illumina, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., QIAGEN, BGI, PerkinElmer Inc., Eurofins Scientific, Macrogen, Inc., PierianDx Key Companies in Next-Generation Sequencing Market are Illumina, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., QIAGEN, BGI, PerkinElmer Inc., Eurofins Scientific, Macrogen, Inc., PierianDx

The Artificial Pancreas Device System (APDS) Market report aims to convey an inexpensive understanding of the business which has been analyzed by using primary and secondary research strategies. the main purpose of this Artificial Pancreas Device System (APDS) Market report

Key Companies in PCR Market are Agilent Technologies, Inc., Qiagen, Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Sysmex Inostic, Abbott, Thermo Fischer Scientific Inc., Eppendorf AG, Other players Key Companies in PCR Market are Agilent Technologies, Inc., Qiagen, Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Sysmex Inostic, Abbott, Thermo Fischer Scientific Inc., Eppendorf AG, Other players

The "Protein Labeling Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com''s offering. The global protein labeling market is expected to grow from $1.6 billion in 2020 to $1.77 billion in 2021 at a compound annual growth rate (CAGR) of 10.6%. The market is expected to reach $2.79 billion in 2025 at a CAGR of 12%. Major players in the protein labeling market are Thermo Fisher Scientific Inc, Merck KGaA, PerkinElmer, Inc., General Electric Company, F. Hoffmann-La Roche AG, Agilent Technologies Inc., BIO-RAD Laboratories, Kirkegaard & Perry Laboratories, LI-COR Inc., and Kaneka Corporation. The protein labeling market consists of sales of protein labeling products and related services by entities (organizations, sole traders and partnerships) that produce protein labeling products to diagnose various diseases. Protein labeling refers to the use of appropriate molecular labels to detect or purify proteins and their binding partners in tissues, cells, and biochemical assays.

The global Life Science and Chemical Instrumentation market size is projected to reach US$ 43080 million by 2026, from US$ 40760 million in 2020, at a CAGR of 5.3%% during 2021-2026. The major vendors covered: Agilent Technologies Inc, Bio-Rad Laboratories Inc, Becton, Dickinson, & Company, Bruker Corporation, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Illumina Inc, PerkinElmer Inc, Danaher Corporation, Shimadzu Corporation, Waters Corporation The global Life Science and Chemical Instrumentation market size is projected to reach US$ 43080 million by 2026, from US$ 40760 million in 2020, at a CAGR of 5.3%% during 2021-2026. The major vendors covered: Agilent Technologies Inc, Bio-Rad Laboratories Inc, Becton, Dickinson, & Company, Bruker Corporation, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Illumina Inc, PerkinElmer Inc, Danaher Corporation, Shimadzu Corporation, Waters Corporation

The study of Hematology Products market is a compilation of the market of Hematology Products broken down into its entirety on the basis of types, application, trends and opportunities, mergers and acquisitions, drivers and restraints, and a global outreach. The

The Global Genechip Scanner Market 2021-2027 research study examines industry growth, market size, top manufacturers, future opportunities, development trends, and estimates for the Genechip Scanner Markets initial and future estimates. Key company profiles with business revenue, CAGR status, future predictions,

New Jersey, United States,- Verified Market Research has recently published a research report titled, Laboratory Analytical Instruments Market Size, and Forecast 2021-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application. Primary and secondary research methodologies have been used to

Railway Pension Investments Ltd raised its position in Agilent Technologies, Inc. (NYSE:A) by 16.9% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 64,184 shares of the medical research companys stock after buying an additional 9,300 shares during the period. Railway Pension Investments Ltds holdings in Agilent []